[CRVS] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 18.67%
YoY- 22.36%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,752 -10,611 -12,978 -11,631 -14,981 -8,645 -20,232 -8.64%
Tax -1 0 0 0 0 0 0 -
NP -11,752 -10,611 -12,978 -11,631 -14,981 -8,645 -20,232 -8.64%
Tax Rate - - - - - - - -
Total Cost 11,752 10,611 12,978 11,631 14,981 8,645 20,232 -8.64%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.28 -0.36 -0.44 -0.40 -0.73 -0.43 -0.99 -18.96%
EPS Diluted -0.28 -0.36 -0.44 -0.40 -0.73 -0.43 -0.99 -18.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.